Elanco Animal Health Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Elanco Animal Health stock has a consensus rating of "Buy" and an average price target of $30.23. The average 1-year stock price forecast is 19.44% higher than the current stock price, while the lowest is $24 (-5.18%) and the highest is $34 (+34.33%).

Price Target: $30.23 (+19.44%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$24	$30.23	$30	$34
Change	-5.18%	+19.44%	+18.53%	+34.33%

Analyst Ratings

The average analyst rating for Elanco Animal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	11	11	11	11	10	9
Buy	5	5	5	4	4	4
Hold	1	1	1	2	2	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	17	17	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Erin Wright Morgan Stanley	Morgan Stanley	Hold Maintains $26 → $25	Hold	Maintains	$26 → $25	-1.22%	Oct 29, 2026
Andrea Alfonso UBS	UBS	Buy Maintains $33	Buy	Maintains	$33	+30.38%	Oct 27, 2026
Keith Devas Jefferies	Jefferies	Hold Downgrades $31 → $24	Hold	Downgrades	$31 → $24	-5.18%	Oct 20, 2026
Chris Schott J.P. Morgan	J.P. Morgan	Buy Maintains $33	Buy	Maintains	$33	+30.38%	Oct 16, 2026
Matthew Dellatorre Goldman Sachs	Goldman Sachs	Buy Initiates $32	Buy	Initiates	$32	+26.43%	Oct 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

5.13B

from 4.72B

8.80%

from 4.72B

Revenue Next Year

5.41B

from 5.13B

5.39%

from 5.13B

EPS This Year

1.13

from 0.94

20.27%

from 0.94

EPS Next Year

1.27

from 1.13

12.56%

from 1.13

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.76B	4.41B	4.42B	4.44B	4.72B	5.13B
Revenue Growth	45.64%	-7.41%	0.14%	0.50%	6.22%	8.80%
Gross Profit	2.70B	2.50B	2.49B	2.44B	2.59B	2.85B
Gross Margin	56.59%	56.63%	56.28%	54.88%	54.99%	55.48%
Operating Income	376.00M	390.00M	331.00M	257.00M	259.00M	883.51M
Net Income	-483.00M	-78.00M	-1.23B	338.00M	-232.00M	63.43M
EPS	-	-	-	-	0.94	1.13
EPS Growth	-	-	-	-	3.30%	20.27%
Forward PE	24.55	12.67	17.64	13.78	23.48	22.39
Free Cash Flow	-	-	-	-	284.00M	472.00M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	5.2B
Avg	5.1B
Low	5.1B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	10.4%
Avg	8.8%
Low	8.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.15
Avg	1.13
Low	1.10

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	22.3%
Avg	20.3%
Low	17.0%